Académique Documents
Professionnel Documents
Culture Documents
Submitted by:
Abbie Dorothy M. Florentin
April 2016
INTRODUCTION
The leukemias are the most common malignant neoplasms in childhood, accounting for
about 31% of all malignancies that occur in children <15 years of age. Each year leukemia is
diagnosed in approximately 3,250 children < 15 years of age in the USA, an annual incidence of
4.5 cases per 100,000 children. Acute lymphoblastic leukemia (ALL) accounts for about 77% of
cases of childhood leukemia, acute myelogenous leukemia (AML) for about 11%, chronic
myelogenous leukemia (CML) for 2 3%, and juvenile myelomonocytic leukemia (JMML) for1
2%.
The leukemias may be defined as a group of malignant diseases in which genetic
abnormalities in a hematopoietic cell give rise to an unregulated clonal proliferation of cells. The
progeny of these cells have a growth advantage over normal cellular elements, because of their
increased rate of proliferation and a decreased rate of spontaneous apoptosis. The result is a
disruption of normal marrow function and, ultimately, marrow failure.1
Leukemia accounted for almost 50% of the total incidence of childhood cancer in the
Philippines. In Metro Manila, Acute Lymphoid Leukemia (ALL) comprised 65% of all
leukemias among children (0-14 years), and 79% of ALL occurred between the ages 1- 9 years.
The 5-year relative survival rate of Metro Manila children with ALLwas lower (34%) compared
to Asian American (87%) and Caucasian children (86%) in the United States. This is also mainly
due to poor access to treatment.
The country is densely populated and the average life expectancy of its population is 68
years. Children under 15 account for 36% of the population. Cancer incidence data for the
country are derived from the two population based cancer registries: Rizal and Manila, which
both cover about 14% of the childhood population. The crude rate for childhood cancer in the
Philippines is 103 annual new cases per million children, which allows prediction of a minimum
of 3500 new cases of childhood cancer. This is the equivalent of almost10 children who will be
diagnosed with cancer each day.2
1
2
cellsproliferate, replacing normal marrow tissue and hematopoietic cells and inducing anemia,
thrombocytopenia, and granulocytopenia. Because they are bloodborne, they can infiltrate
various organs and sites, including the liver, spleen, lymph nodes, CNS, kidneys, and gonads.3
Leukemia is one of the commonest of childhood cancers, and accounts for one third of total
childhood malignancies. The annual incidence of leukemia is 42.1/million white children and
24.3/million black children. Approximately 20,500 new cases in adults, and 2500 in children are
dignosed annually in United States alone, and the disease causes about 15900 deaths a year.
Like all other neoplasias, the etiology of leukemia also remains elusive. However, certain
etiologic factors like viruses, radiations, toxic chemicals, and heredity and congenital disorders
have worth mentioning roles. Down Syndrome, Li Fraumeni Syndrome, Ataxia
telangiectasia, Wiscot Aldrich Syndrome are some of the genetic syndrome and inherited
disorders that increases risk of a child having leukemia.4
Exposure to high levels of radiation is a risk factor for childhood leukemia.The possible
risks from fetal or childhood exposure to lower levels of radiation, such as from x-ray tests or CT
scans, are not known for sure. Some studies have found a slight increase in risk, while others
have found no increased risk. Any risk increase is likely to be small, but to be safe, most doctors
recommend that pregnant women and children not get these tests unless they are absolutely
needed.5
Exposure to chemicals such as benzene (a solvent used in the cleaning industry and to
manufacture some drugs, plastics, and dyes) may cause acute leukemia in adults and, rarely, in
children. Several studies have found a possible link between childhood leukemia and household
exposure to pesticides, either during pregnancy or early childhood. Some studies have also found
a possible increased risk among mothers with workplace exposure to pesticides before birth.6
Leukemias clinically present with fever, pallor, bruising, bleeding and bone pains,
occurring in any combination. Anemia, petechiae, bruising, ecchymosis, lymphadenopathy,
visceromegaly and bone tenderness are common signs of eukemia7
3
4
5
6
7
METHODOLOGY
The data that will be gathered on each patient will be encoded using MS Excel with the use of a
code system based on the presence and absence of the variables identified.
DATA ANALYSIS
The data will be analysed using a descriptive statistical tool such as construction of frequency
distribution and percentage computation.
Table 1. Sociodemographic Profile of Patients with Childhood Leukemia admitted at EVRMC,
Department of Pediatrics
Demographic Profile
Age:
0 - < 1 y.o
1 5 y.o.
6-10 y.o.
More than 10 y.o.
Sex:
Male
Female
Socioeconomic Status:
High income class
Middle income class
Low income class
Residence:
Leyte
1st District
2nd District
3rd District
4th District
5th District
Southern Leyte
1st District
2nd District
Biliran
Samar
1st District
2nd District
Eastern Samar
Northern Samar
1st District
Number of Patients
Percentage
2nd District
Table 2: Clinical Profile of Patients with Childhood Leukemia admitted at EVRMC, Department
of Pediatrics
Clinical Profile
Chief complaint:
Fever
Easy Bruising
Pallor
Bleeding
Epistaxis
Gum bleeding
Melena
Hematochezia
Abdominal enlargement
Weight loss
Number of Patients
Percentage
Physical Examination
Findings:
Pallor
Bruising
Lymphadenopathies
Visceromegaly
Hepatomegaly
Splenomegaly
Hepatosplenomegaly
Bone tenderness
Table 3: Possible Etiology or Prediposing Factors of Patients with Childhood Leukemia admitted
at EVRMC, Department of Pediatrics
Number of Patients
Genetic/hereditary conditions
Downs Syndrome
Fanconi Syndrome
WAS
Frequency
Environmental factors
Radiation
Toxic Chemicals
Number of Patients
Frequency
Number of Patients
Frequency
ETHICAL CONSIDERATIONS
The study will involve a review of the medical records of the patients with childhood leukemia
who were admitted at Eastern Visayas Regional Medical Center, Department of Pediatrics. An
approval of the study will be obtained from the Chairman of the Pediatrics Department of the
hospital as well as from the Head of the Research Committee of the department. A formal letter
will be sent to Eastern Visayas Regional Medical Center and to the Head of the Records Section.
A written formal consent will no longer be obtained from the parents of the subjects. The name
of the subjects will not be revealed; only their initials will appear in the document.
REFERENCES
1. Tubergen David, Bleyer Archie, Ritchey Kim. Nelson Textbook of Pediatrics 19th ed: The
Leukemias. Singapore: Elsevier; 2012. P1732
2. Lecciones, Julius. The global improvement of childhood cancer care in the Philippines.
Cancer Control
3. Rytting, Michael. The Merck Manuals